. 2020 Dec 14;77(2):205–213. doi: 10.1016/j.mjafi.2020.09.009

Table 5.

MRI in presurgical evaluation.

Tumor diameter (TD)	TD on the HPR		Total	Sensitivity: 91.67%, specificity: 73.91% NPV: 89.47% PPV: 78.57%, accuracy: 82.98%
Tumor diameter (TD)	TD>2 cm	TD <2 cm	Total
TD>2 cm on MRI	44	12	56
TD<2 cm on MRI	04	34	38
Total	48	46	94
Myometrial invasion (MI)	MI on the HPR		Total	Sensitivity: 85.71%, specificity: 89.47%, NPV: 92.30%, PPV: 40.42%, accuracy: 87.20%
Myometrial invasion (MI)	MI >50%	MI <50%	Total
MI >50% on MRI	48	04	52
MI <50% on MRI	08	34	42
Total	56	38	94
Cervical disease	Cervical involvement on the HPR		Total	Sensitivity: 66.67%, specificity: 100%, NPV: 97.78%, PPV: 100%, accuracy: 97.87%
Cervical disease	+	–	Total
Cx Inv on MRI, +	4	0	04
Cx Inv on MRI, –	2	88	90
Total	06	88	94
LN metastasis	LN metastasis on the HPR			Sensitivity: 54.55%, specificity: 94.44%, NPV: 87.18%, PPV: 75.00%, accuracy: 85.11%
LN metastasis	+	–
LN on MRI, +	12	04	16
LN on MRI, –	10	68	78
Total	22	72	94

Cx Inv, Cervical involvement; MRI, magnetic resonance imaging; HPR, final histopathology report; LN, lymph node; NPV, negative predictive value; PPV, positive predictive value.